Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 292
8
Diseases
8
Unique genes
0.227
Avg. similarity score
Complement pathway abnormality
Most-connected disease (7 links)
Disease
Searched: Systemic lupus erythematosus related to C1QA
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Systemic lupus erythematosus related to C1QA
Complement pathway abnormality
Immunodeficiency due to a classical component pathway complement deficiency
C1q deficiency
Periodontal ehlers-danlos syndrome
C1s deficiency
C4a deficiency
Immunodeficiency due to an early component of complement deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Complement pathway abnormality | 7 | 7 | 8 |
| Immunodeficiency due to a classical component pathway complement deficiency | 5 | 5 | 4 |
| C1q deficiency | 4 | 4 | 3 |
| Periodontal ehlers-danlos syndrome | 3 | 3 | 2 |
| Systemic lupus erythematosus related to C1QA | 3 | 3 | 1 |
| C1s deficiency | 2 | 2 | 1 |
| C4a deficiency | 2 | 2 | 1 |
| Immunodeficiency due to an early component of complement deficiency | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| C1QA | 4 / 8 | C1q deficiency, Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency, Systemic lupus erythematosus related to C1QA |
| C1QB | 3 / 8 | C1q deficiency, Complement pathway abnormality, Immunodeficiency due to an early component of complement deficiency |
| C1QC | 3 / 8 | C1q deficiency, Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency |
| C1R | 3 / 8 | Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency, Periodontal ehlers-danlos syndrome |
| C1S | 3 / 8 | C1s deficiency, Complement pathway abnormality, Periodontal ehlers-danlos syndrome |
| C4A | 3 / 8 | C4a deficiency, Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Initial triggering of complement | Reactome | 8 / 17 | 706× | 2.27e-24 | 3.34e-21 ✓ sig. |
| Regulation of Complement cascade | Reactome | 8 / 47 | 256× | 2.94e-20 | 2.24e-17 ✓ sig. |
| Pertussis | KEGG | 8 / 78 | 154× | 2.19e-18 | 1.27e-15 ✓ sig. |
| Complement and coagulation cascades | KEGG | 8 / 88 | 136× | 6.00e-18 | 3.24e-15 ✓ sig. |
| Staphylococcus aureus infection | KEGG | 8 / 99 | 121× | 1.60e-17 | 7.90e-15 ✓ sig. |
| Classical antibody-mediated complement activation | Reactome | 5 / 6 | 1,251× | 1.61e-16 | 6.46e-14 ✓ sig. |
| Systemic lupus erythematosus | KEGG | 8 / 140 | 85.8× | 2.79e-16 | 1.08e-13 ✓ sig. |
| Coronavirus disease - COVID-19 | KEGG | 8 / 238 | 50.5× | 2.12e-14 | 5.65e-12 ✓ sig. |
| Alcoholic liver disease | KEGG | 6 / 144 | 62.6× | 7.35e-11 | 8.97e-9 ✓ sig. |
| Activation of C3 and C5 | Reactome | 3 / 8 | 563× | 1.08e-8 | 7.96e-7 ✓ sig. |
| Chagas disease | KEGG | 3 / 103 | 43.7× | 3.33e-5 | 7.90e-4 ✓ sig. |
| Efferocytosis | KEGG | 3 / 157 | 28.7× | 1.17e-4 | 2.14e-3 ✓ sig. |
| Prion disease | KEGG | 3 / 275 | 16.4× | 6.11e-4 | 7.81e-3 ✓ sig. |
| Post-translational protein phosphorylation | Reactome | 2 / 108 | 27.8× | 2.17e-3 | 2.02e-2 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 2 / 125 | 24.0× | 2.89e-3 | 2.48e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| complement activation, classical pathway | GO:0006958 | 8 / 37 | 505× | 1.05e-22 | 2.45e-19 ✓ sig. |
| complement activation | GO:0006956 | 7 / 35 | 467× | 3.41e-19 | 4.84e-16 ✓ sig. |
| opsonization | GO:0008228 | 5 / 18 | 649× | 2.52e-14 | 1.62e-11 ✓ sig. |
| innate immune response | GO:0045087 | 8 / 605 | 30.9× | 1.15e-12 | 5.41e-10 ✓ sig. |
| activation of membrane attack complex | GO:0001905 | 4 / 13 | 719× | 9.84e-12 | 3.77e-9 ✓ sig. |
| immune system process | GO:0002376 | 8 / 943 | 19.8× | 4.09e-11 | 1.37e-8 ✓ sig. |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 / 6 | 1,168× | 1.03e-9 | 2.38e-7 ✓ sig. |
| synapse pruning | GO:0098883 | 3 / 7 | 1,001× | 1.80e-9 | 3.88e-7 ✓ sig. |
| complement activation, GZMK pathway | GO:0160257 | 3 / 12 | 584× | 1.13e-8 | 1.96e-6 ✓ sig. |
| killing of cells of another organism | GO:0031640 | 4 / 104 | 89.8× | 6.23e-8 | 8.54e-6 ✓ sig. |
| protein maturation | GO:0051604 | 4 / 134 | 69.7× | 1.73e-7 | 2.00e-5 ✓ sig. |
| complement activation, lectin pathway | GO:0001867 | 2 / 13 | 359× | 1.25e-5 | 6.46e-4 ✓ sig. |
| zymogen activation | GO:0031638 | 2 / 32 | 146× | 7.90e-5 | 2.60e-3 ✓ sig. |
| vertebrate eye-specific patterning | GO:0150064 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| detection of molecule of bacterial origin | GO:0032490 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |